Access cutting-edge severe hypertriglyceridemia treatment through this clinical trial at a research site in Springfield. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Springfield location
Access severe hypertriglyceridemia specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related severe hypertriglyceridemia treatment provided free
Check if you qualify for this severe hypertriglyceridemia clinical trial in Springfield, IL
No-Cost Study Care
Local to Springfield
Convenient for IL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study will evaluate the efficacy and safety of plozasiran in approximately 140 adult participants with severe hypertriglyceridemia (SHTG) and history of at least two prior acute pancreatitis (AP) events not attributed to other etiologies, with at least one occurring within the last 12 months prior to screening. Eligible participants will be randomly assigned in a double-blind manner to either receive plozasiran 25 mg by subcutaneous (SC) injection every three months (Q3M) or matching placeb
Sponsor: Arrowhead Pharmaceuticals
Yes, this clinical trial (NCT06880770) has an active research site in Springfield, IL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for severe hypertriglyceridemia treatment options in Springfield, IL, this clinical trial (NCT06880770) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Springfield research site is actively enrolling participants for this clinical trial. You'll receive care from experienced severe hypertriglyceridemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all severe hypertriglyceridemia clinical trials near you to find additional studies recruiting in your area.
See all heart attack clinical trials recruiting in Springfield — not just this study.
Browse Heart Attack Trials in Springfield →